Clinical Trial Update: Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

View source ↗

Summary

This completed observational study assesses fluid resolution and the overall effectiveness of Beovu (brolucizumab) in patients with neovascular age-related macu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• BEOVU (BROLUCIZUMAB)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME) | Status: COMPLETED